WHO ICTRP trial
Thymine test for 5-fluorouracil side effects
ACTRN12615000586516 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12615000586516 |
|---|---|
| Public title | Thymine test for 5-fluorouracil side effects |
| Scientific title | An observational case-control study to detect predisposition to 5-fluorouracil/capecitabine-related toxicity using a thymine test in gastrointestinal cancer patients |
| Primary sponsor | The University of Auckland |
| Secondary sponsors | not applicable |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | New Zealand |
| Conditions | Gastrointestinal cancers; Gastrointestinal cancers;Cancer - Bowel - Back passage (rectum) or large bowel (colon);Cancer - Bowel - Small bowel (duodenum and ileum);Cancer - Breast |
| Interventions | Participants are administered a single dose of thymine (250 mg, orally) at any time prior to, or after completion of, a cycle of 5-fluorouracil/capecitabine treatment course. A cumulative 4 h urine sample is collected for detemination of… |
| Registration date | Apr 6, 2015 |
| Target size | 70 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: